Europäische Union - Lettisch - EMA (European Medicines Agency)

laboratorios hipra s.a. - dzīvas novājinātas liellopu elpošanas syncytial vīruss (brsv), celms, lym-56 - immunologicals par bovidae, govis, dzīvu vīrusu vakcīnas, liellopu elpošanas syncytial vīruss (brsv) - liellopi - aktīvās imunizācijas liellopiem, lai samazinātu vīrusu izplatīšanos un elpošanas klīniskās pazīmes, ko izraisa govju elpošanas syncytial vīrusu infekcija.

Europäische Union - Lettisch - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - cūkas - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

Europäische Union - Lettisch - EMA (European Medicines Agency)

laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - cūkas - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.

Europäische Union - Lettisch - EMA (European Medicines Agency)

laboratorios farmacéuticos rovi, s.a. - risperidons - Šizofrēnija - psihoterapija - treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.

Lettland - Lettisch - Pārtikas un veterinārais dienests, Zemkopības ministrija

laboratorios calier, s.a., spānija - enrofloxacin - šķīdums injekcijām - 100 mg/ml - cūkas; liellopi

Lettland - Lettisch - Pārtikas un veterinārais dienests, Zemkopības ministrija

laboratorios hipra s.a., spānija - dzīvas novājinātas vta vīruss, celms vp-046 bis - liofilizāts un šķīdinātājs suspensijas injekcijām pagatavošanai - cūkas

Lettland - Lettisch - Pārtikas un veterinārais dienests, Zemkopības ministrija

laboratorios calier, s.a., spānija - fipronils - uz ādas lietojams aerosols, šķīdums - 2,5 mg/ml - kaķi; suņi

Lettland - Lettisch - Pārtikas un veterinārais dienests, Zemkopības ministrija

laboratorios syva s.a.u, spānija - atipamezols hidrohlorīds - šķīdums injekcijām - 5 mg/ml - kaķi; suņi

Lettland - Lettisch - Pārtikas un veterinārais dienests, Zemkopības ministrija

laboratorios calier, s.a., spānija - toltrazurils - šķīdums lietošanai ar dzeramo ūdeni - 25 mg/ml - vistas

Lettland - Lettisch - Pārtikas un veterinārais dienests, Zemkopības ministrija

laboratorios calier, s.a., spānija - toltrazurils - suspensija iekšķīgai lietošanai - 50 mg/ml - cūkas